Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

December 31, 2022

Conditions
Adverse Reaction to Diagnostic Agents and Kits Nos
Interventions
BIOLOGICAL

19F Cell Sense-labeled PBMC

"Peripheral blood mononuclear cells (PBMC) will be isolated from patient whole blood samples and labeled in a GMP facility with GMP grade 19F Cell Sense imaging agent.~These cells will be re-administered to the patient prior to imaging."

DEVICE

MRI

Participants will undergo Magnetic Resonance Imaging (MRI) at 1 hour and 24 hours following PBMC administration

Trial Locations (1)

N6A 5B7

Robarts Research Institute, London

Sponsors
All Listed Sponsors
collaborator

Western University, Canada

OTHER

collaborator

Ontario Institute for Cancer Research

OTHER

lead

Gregory A. Dekaban

OTHER